NKG2A + CD8 + T cells infiltration determines immunosuppressive contexture and inferior response to immunotherapy in clear cell renal cell carcinoma
Journal for ImmunoTherapy of Cancer · 2024
DOI: 10.1136/jitc-2023-008368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2024. Verfasst von Youqi Qiu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Carcinoma. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shanghai Municipal Health Bureau Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Immunotherapy is gaining momentum, but current treatments have limitations in terms of beneficiaries. Clear cell renal cell carcinoma (ccRCC) harbors the highest expression of human leukocyte antigen E (HLA-E), ligand of NKG2A, among all solid tumors. In this study, we aim to investigate the role of NKG2A + CD8 + T cells in tumor microenvironment and its potential as a novel target in ccRCC.
Methods
This study included four independent cohorts, including 234 patients from Zhongshan cohort (ZSHC) who underwent partial or radical nephrectomy at Zhongshan Hospital, and 117 metastatic patients from metastatic Zhongshan cohort (ZSHC-metastatic renal cell carcinoma) who were treated with immune checkpoint inhibitor or tyrosine kinase inhibitor alone. We also incorporated a cohort of 530 patients diagnosed with ccRCC from The Cancer Genome Atlas (referred to as TCGA-kidney renal clear cell carcinoma) and 311 patients from CheckMate cohort for bioinformatics exploration and hypothesis validation. Fresh surgical specimens from 15 patients who underwent ccRCC surgery at Zhongshan Hospital were collected for flow cytometry analysis. Another 10 fresh surgical specimens were used to investigate the therapeutic potential of NKG2A blockade after in vitro intervention. The infiltration of NKG2A + CD8 + T cells was assessed using immunohistochemical staining, flow cytometry, and immunofluorescence staining in ZSHC cohort.
Results
Patients with higher infiltration of NKG2A + CD8 + T cells in ccRCC exhibited shorter overall survival and resistance to immunotherapy. NKG2A + CD8 + T cells expressed upregulated checkpoint molecules and displayed impaired effector functions, along with tissue-residency characteristics. Combination of programmed cell death protein-1 (PD-1) blockade and NKG2A blockade demonstrated an enhanced capability in reactivating CD8 + T cells effector functions.
Conclusion
Intense infiltration of NKG2A + CD8 + T cells were associated with poorer prognosis and response to immunotherapy. NKG2A blockade combined with current immunotherapy exhibited a robust ability to reactivate CD8 + T cells effector functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China guo.jianming@zs-hospital.sh.cn jjxufdu@fudan.edu.cn.
- NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China guo.jianming@zs-hospital.sh.cn jjxufdu@fudan.edu.cn.
ORCID-Profile: Jiejie Xu
Förderung
- Shanghai Municipal Health Bureau Project
- National Natural Science Foundation of China
Zitieren
APA
Qiu, Y., Liu, L., Jiang, W., Xu, Z., Wang, J., Dai, S., Guo, J., & Xu, J. (2024). NKG2A + CD8 + T cells infiltration determines immunosuppressive contexture and inferior response to immunotherapy in clear cell renal cell carcinoma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2023-008368
Vancouver
Qiu Y, Liu L, Jiang W, Xu Z, Wang J, Dai S, et al. NKG2A + CD8 + T cells infiltration determines immunosuppressive contexture and inferior response to immunotherapy in clear cell renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 2024. doi:10.1136/jitc-2023-008368
BibTeX
@article{Qiu2024,
author = {Qiu, Youqi and Liu, Li and Jiang, Wenbin and Xu, Ziyang and Wang, Jiahao and Dai, Siyuan and Guo, Jianming and Xu, Jiejie},
title = {NKG2A + CD8 + T cells infiltration determines immunosuppressive contexture and inferior response to immunotherapy in clear cell renal cell carcinoma},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2024},
doi = {10.1136/jitc-2023-008368}
}
EUVIMED